Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Copenhagen Stock Exchange  >  H. Lundbeck A/S    LUN   DK0010287234

H. LUNDBECK A/S (LUN)

39
Delayed Quote. Delayed CHI-X EUROPE LIMITED. - 06/29 04:59:59 pm
130.5000 DKK   -0.31%
06/23 H LUNDBECK A/S : Young adult patients* with schizophrenia show impro..
06/15 H LUNDBECK A/S : Analysis of Responder Data from Clinical Trials Eva..
06/14 H LUNDBECK A/S : Major shareholder announcement
SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Engages in the research, development, production and sale of pharmaceuticals for the treatment of brain diseases

H. Lundbeck A/S is engaged in the research, development, production and sale of pharmaceuticals for the treatment of brain diseases.

It focuses in alcohol dependence, Alzheimer's disease, bipolar disorder, depression/anxiety, epilepsy, Huntington's disease, Parkinson's disease, schizophrenia, stroke and symptomatic neurogenic orthostatic hypotension.

The company was founded by Hans Lundbeck on August 14, and is headquartered in Valby, Denmark.

Number of employees : 5 811 persons.
Sales per Businesses
20132014Delta
DKK (in Million)%DKK (in Million)%
Cipralex5,93338.9%4,64734.5% -27.67%
Ebixa2,09613.7%1,0587.9% -98.11%
Other Pharmaceuticals1,83012%1,98514.7% +7.81%
Other Revenue1,4849.7%547.004.1% -171.3%
Xenazine1,4209.3%1,69512.6% +16.22%
Azilect1,3929.1%1,49711.1% +7.01%
Onfi573.003.8%923.006.9% +37.92%
Sabril530.003.5%716.005.3% +25.98%
Treanda--212.001.6%-
Brintellix--188.001.4%-
Sales per Regions
20132014Delta
DKK (in Million)%DKK (in Million)%
Rest of Europe7,02846.1%4,99137.1% -40.81%
Rest of the World4,07526.7%4,14430.8% +1.67%
United States2,63517.3%3,75827.9% +29.88%
Denmark36.000.2%28.000.2% -28.57%
Other Revenue--547.004.1%-
Managers
NameAgeSinceTitle
Kåre Schultz542015President & Chief Executive Officer
Sven Håkan Björklund MD, PhD582011Chairman
Anders Götzsche482007CFO & Executive VP-Information Technology
Anders Gersel Pedersen MD, PhD642000Executive Vice President-Research & Development
Thorleif Krarup632004Director
Jørn Møller Mayntzhusen, MBA492002Director & Senior Manager-Supply Optimisation
Christian Peter Dyvig, MBA512011Deputy Chairman
Mona Elisabeth Elster531994Director
Melanie Georgina Lee, PhD572012Independent Non-Executive Director
Lars Søren Rasmussen562013Director
Shareholders
NameShares%
Lundbeck Foundation 137,351,918 69.9%
Wellington Management Co. LLP 9,866,717 5.02%
Norges Bank Investment Management 2,735,002 1.39%
OppenheimerFunds, Inc. 2,400,000 1.22%
Templeton Global Advisors Ltd. 1,748,890 0.89%
M&G Investment Management Ltd. 1,539,733 0.78%
Franklin Templeton Investment Management Ltd. 1,308,710 0.67%
Brandes Investment Partners LP 1,087,515 0.55%
Teachers Advisors, Inc. 1,016,088 0.52%
The Vanguard Group, Inc. 913,095 0.46%
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Pharmaceuticals - NEC
Advertisement
Sector Pharmaceuticals
Growth (Revenue) Profitability
JOHNSON & JOHNSON
NOVARTIS AG
ROCHE HOLDING LTD..
PFIZER INC.
MERCK & CO., INC.
SANOFI
BAYER AG
ALLERGAN PLC
NOVO NORDISK A/S
BRISTOL-MYERS SQU..
GLAXOSMITHKLINE P..
ELI LILLY AND CO
VALEANT PHARMACEU..
ABBOTT LABORATORI..
TEVA PHARMACEUTIC..
REGENERON PHARMAC..
SHIRE PLC
TAKEDA PHARMACEUT..
MYLAN NV
ASTELLAS PHARMA I..
Sector Pharmaceuticals
H. Lundbeck A/S : Connections
Fonden Lundbeck International Neuroscience Foundation
Confederation of Danish Industry
Atos Medical AB
Danmark Amerika Fondet
Sport ONE Danmark A/S
LEGO A/S
Falck Danmark A/S
UNA Invest ApS
Lundbeck Foundation
C.P. Dyvig & Co. A/S
The Crown Prince Frederik Fond
Lundbeck Cognitive Therapeutics A/S
Bisca A/S
European Society for Medical Oncology
FIH Erhvervsbank A/S
American Society of Clinical Oncology
NightstaRx Ltd.
International Association for the Study of Lung Cancer
Danish Society of Medical Oncology
MT Højgaard A/S
Danish Society of Internal Medicine
Company contact information
H. Lundbeck A/S
Ottiliavej 9
Valby, Capital Region 2500

Phone : +45.36.30.13.11
Fax : +45.36.30.19.40
Web : www.lundbeck.com
© 2015 People , Fundamentals and Ownership